scholarly journals Hypnotherapy in Palliative Care

1996 ◽  
Vol 89 (9) ◽  
pp. 493-496 ◽  
Author(s):  
I G Finlay ◽  
O L Jones
Keyword(s):  
Palliative Care ◽  
Complementary Therapies ◽  
Care Setting ◽  
Complementary Therapy ◽  
Negative Effects ◽  
Patients With Cancer ◽  
Formal Evaluation ◽  
Retrospective Questionnaire ◽  
Pleasant Experience ◽  
Evaluation Sheet

Complementary therapies have found increasing vogue in the management of patients with cancer, although little formal evaluation has been undertaken. We report on our experience of offering hynotherapy to palliative care outpatients in a hospice day care setting. During 2½ years, 256 patients had hypnotherapy, all singly; two-thirds (n=104) were women. Only 13% (n=21) had four or more treatment sessions. At the time of survey, the 52 patients still alive were mailed an evaluation sheet, of whom 41 responded. 61 % reported improved coping with their illness. 7% (n=3) reported harmful or negative effects from hypnotherapy. Amongst those whose coping was unchanged, many found the therapy a pleasant experience. 35 respondents (85%) appended positive comments to their questionnaire returns. Despite the limitations of a retrospective questionnaire, our findings suggest that hypnotherapy, used within strict guidelines in patients with advanced cancer, is a safe complementary therapy to enhance coping.

Patterns of knowledge and use of medical cannabis among Brazilian oncologists and palliative care physicians.

2021 ◽  
Vol 39 (15_suppl) ◽  
pp. e24099-e24099
Author(s):  
Júlia Maria Mathias Pedreira de Freitas ◽  
Daniela Oliveira de Almeida ◽  
Luciana Castro G. Landeiro ◽  
Tércia Vilasboas Reis ◽  
Thomas Azevedo de Carmo ◽  
...  
Keyword(s):  
Palliative Care ◽  
Online Survey ◽  
Scientific Evidence ◽  
Complementary Therapy ◽  
Medical Cannabis ◽  
Patients With Cancer ◽  
Brazilian Legislation ◽  
Oncological Diseases ◽  
Care Outcomes ◽  
Lack Of Knowledge

e24099 Background: Medical cannabis (MC) emerged as an important complementary therapy in the context of oncological diseases. In 2019, the Brazilian Health Regulatory Agency (Anvisa) approved use of MC, which can be produced in the country and sold in pharmacies under medical prescription. Previous investigations have extensively correlated MC effectiveness, over management and support of symptoms caused by the disease and/ or its treatment. However, studies evaluating knowledge and patterns of MC use in oncology patients MC are lacking. In the present study, we assessed the perception of oncologists and palliative care physicians on MC as a complementary therapy for cancer patients, and their personal experiences in clinical practice in Brazil. Methods: In October 2020 an online survey was sent via e-mail by the Brazilian Society of Clinical Oncology and the National Academy of Palliative Care for physicians with expertise in oncology and/or palliative care. Outcomes measured included knowledge and opinions about MC, prescription experience and impressions about the Brazilian legislation. Data analysis was performed with descriptive statistics, comparison tests and the Poisson regression model with robust variance, using the IBM Statistical Package for the Social Sciences software, version 25. Results: A total of 124 physician participated in the study and, of those, 58.1% were oncologists, and 82.3% believed that MC has application as a complementary therapy in cancer. In contrast, only 52.4% of the participants felt comfortable recommending its use and only 15.3% have ever prescribed MC for their patients with cancer. Further, among those who have never prescribed, 71% have already referred patients to other professionals to prescribe, and 61% indicated lack of knowledge as the main factor for not prescribing. In addition, more than half of participants claimed not knowing Brazilian legislation regarding MC use. Nausea and vomiting were mentioned by 73.4% of physicians as the major indication for MC. Conclusions: Oncologists and palliative care physicians agree with the applicability of MC use for the management of symptoms related with or caused by cancer. However, our findings infer that factors such as lack of knowledge, legislation barriers and lack of robust scientific evidence, lead to its limited use among Brazilian oncologists and palliative care physicians.

scholarly journals Efficacy of the complementary therapies in the management of cancer pain in palliative care: A systematic review

2020 ◽  
Vol 28 ◽  
Author(s):  
Luís Carlos Lopes-Júnior ◽  
Gabriela Sylvestre Rosa ◽  
Raphael Manhães Pessanha ◽  
Sara Isabel Pimentel de Carvalho Schuab ◽  
Karolini Zuqui Nunes ◽  
...  
Keyword(s):  
Systematic Review ◽  
Palliative Care ◽  
Cancer Pain ◽  
Complementary Therapies ◽  
Data Extraction ◽  
Muscle Relaxation ◽  
Massage Therapy ◽  
Complementary Therapy ◽  
Progressive Muscle Relaxation ◽  
Manual Search

Objective: to synthesize the knowledge and to critically evaluate the evidences arising from randomized controlled trials on the efficacy of the complementary therapies in the management of cancer pain in adult patients with cancer in palliative care. Method: a systematic review guided by the Preferred Reporting Items for Systematic Reviews and Meta-Analyses. The search for articles in the MEDLINE, ISI Web of Knowledge, CENTRAL Cochrane, and PsycINFO databases, as well as the manual search, selection of studies, data extraction, and methodological assessment using the Cochrane Bias Risk tool were performed independently by two reviewers. Results: eight hundred and fifteen (815) studies were identified, six of them being selected and analyzed, of which three used massage therapy, one study used a combination of progressive muscle relaxation and guided imaging, and another two studies used acupuncture. Most of the studies had an uncertain risk of bias (n=4; 67%). Conclusion: while the evidence from the studies evaluating the use of massage therapy or the use of progressive muscle relaxation and guided imaging for the management of cancer pain in these patients demonstrated significant benefits, the other two studies that evaluated the use of acupuncture as a complementary therapy showed contradictory results, therefore, needing more research studies to elucidate such findings.

scholarly journals Complementary therapy in palliative care: A synthesis of qualitative and quantitative systematic reviews

2020 ◽  
Vol 34 (10) ◽  
pp. 1332-1339
Author(s):  
Megan Armstrong ◽  
Nuriye Kupeli ◽  
Kate Flemming ◽  
Patrick Stone ◽  
Susie Wilkinson ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Palliative Care ◽  
Systematic Reviews ◽  
Complementary Therapies ◽  
Complementary Therapy ◽  
Qualitative Studies ◽  
Perceived Benefits ◽  
Qualitative Synthesis ◽  
Qualitative And Quantitative

Background: Interventions delivered in palliative care are complex and their evaluation through qualitative and quantitative research can lead to contrasting results. In a systematic review of trials, the effectiveness results of complementary therapies in palliative care were inconclusive; however, our qualitative synthesis showed participants perceived them to be beneficial. Aim: Use a novel methodology to synthesise evidence from qualitative and quantitative systematic reviews on complementary therapy in palliative care to explore the following: (1) If interventions delivered in trials reflect how participants in qualitative studies report they are delivered in real-life settings and (2) whether quality of life measures used in trials capture perceived benefits that are reported in qualitative studies. Methods: Two matrix tables were formulated. In one, key components in delivery of the complementary therapy from the qualitative synthesis which are as follows: (1) relationship with therapist, (2) comfortable environment, (3) choices (e.g. area of massage) and (4) frequent sessions, were plotted against intervention description, to explore matches and mismatches. In the other, items included in quality of life scales were compared with perceived benefits of complementary therapy. Results: None of the trials included all four key delivery components. The five quality of life scales used in the trials failed to capture the range of perceived benefits from the complementary therapies and many included inappropriate or redundant items. Conclusions: By integrating qualitative and quantitative review data, we determined the reasons trials may be inconclusive. This methodological exemplar provides a framework for understanding complexity in outcomes across trials and a direction for future research.

scholarly journals Symptom clusters in patients with cancer in the hospice/palliative care setting

2016 ◽  
Vol 24 (9) ◽  
pp. 3863-3871 ◽  
Author(s):  
Stephen J. Stapleton ◽  
Janean Holden ◽  
Joel Epstein ◽  
Diana J. Wilkie
Keyword(s):  
Palliative Care ◽  
Care Setting ◽  
Symptom Clusters ◽  
Patients With Cancer ◽  
Palliative Care Setting ◽  
Hospice Palliative Care

Pattern of Hospitalization of Patients With Cancer in an Acute Palliative Care Setting

2012 ◽  
Vol 30 (1) ◽  
pp. 25-28 ◽  
Author(s):  
Sadeer G. Al-Kindi ◽  
Ghaith F. Abu Zeinah ◽  
Azza Adel Hassan
Keyword(s):  
Palliative Care ◽  
Care Setting ◽  
Average Length ◽  
Wealthy Country ◽  
Gastrointestinal Malignancies ◽  
Patients With Cancer ◽  
Average Length Of Stay ◽  
Palliative Care Setting ◽  
Specialized Palliative Care ◽  
Palliative Care Units

Palliative care is an essential part of in cancer treatment. Specialized palliative care units are starting to be incorporated into advanced healthcare systems. Qatar, a wealthy country in the Middle East, opened its first acute palliative care unit within a specialty cancer hospital in 2008. The objective of this study is to report and analyze the patterns of admissions and discharges of the patients referred to this unit over a period of three years. Our unit received 241 total admissions from July 2008 to June 2011. The age of the patients was 60.5 years, with 41.6% being local Qataris. Gastrointestinal malignancies formed the most common (34.5%). The average length of stay per admission at this unit was 30.5 days. The in-hospital mortality in our unit was 61.7%. The LOS and mortality rates were higher than those reported in the literature. We attributed that to the lack of other models of palliative care in the country and to cultural factors.

scholarly journals Symptom clusters and their influence on prognosis using EORTC QLQ-C15-PAL scores in terminally ill patients with cancer

2021 ◽  
Author(s):  
Nanako Koyama ◽  
Chikako Matsumura ◽  
Yuuna Tahara ◽  
Morito Sako ◽  
Hideo Kurosawa ◽  
...  
Keyword(s):  
Palliative Care ◽  
Terminally Ill ◽  
Symptom Clusters ◽  
Rank Test ◽  
Appetite Loss ◽  
Patients With Cancer ◽  
Terminally Ill Patients ◽  
Log Rank Test ◽  
Eortc Qlq ◽  
Cluster 2

Abstract Purpose The aims of the present study were to investigate the symptom clusters in terminally ill patients with cancer using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 15 Palliative Care (EORTC QLQ-C15-PAL), and to examine whether these symptom clusters influenced prognosis. Methods We analyzed data from 130 cancer patients hospitalized in the palliative care unit from June 2018 to December 2019 in an observational study. Principal component analysis was used to detect symptom clusters using the scored date of 14 items in the QLQ-C15-PAL, except for overall QOL, at the time of hospitalization. The influence of the existence of these symptom clusters and Palliative Performance Scale (PPS) on survival was analyzed by Cox proportional hazards regression analysis, and survival curves were compared between the groups with or without existing corresponding symptom clusters using the log-rank test. Results The following symptom clusters were identified: cluster 1 (pain, insomnia, emotional functioning), cluster 2 (dyspnea, appetite loss, fatigue, and nausea), and cluster 3 (physical functioning). Cronbach’s alpha values for the symptom clusters ranged from 0.72 to 0.82. An increased risk of death was significantly associated with the existence of cluster 2 and poor PPS (log-rank test, p = 0.016 and p < 0.001, respectively). Conclusion In terminally ill patients with cancer, three symptom clusters were detected based on QLQ-C15-PAL scores. Poor PPS and the presence of symptom cluster that includes dyspnea, appetite loss, fatigue, and nausea indicated poor prognosis.

Sign in / Sign up

Export Citation Format

Share Document